| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/25/2006 | EP1618888A1 Production of human papillomavirus capsid protein and virus-like particles |
| 01/25/2006 | EP1618205A2 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 01/25/2006 | EP1618191A2 Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 01/25/2006 | EP1618185A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/25/2006 | EP1618184A2 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
| 01/25/2006 | EP1618181A2 Polyvalent protein complex |
| 01/25/2006 | EP1618130A2 Therapeutic cancer vaccine |
| 01/25/2006 | EP1618128A1 Tuberculosis vaccine with improved efficacy |
| 01/25/2006 | EP1618127A2 The severe acute respiratory syndrome coronavirus |
| 01/25/2006 | EP1618126A2 Sars-related proteins |
| 01/25/2006 | EP1617871A2 Delivery of immune response modifier compounds using metal-containing particulate support materials |
| 01/25/2006 | EP1617870A2 Single chain antigen-binding polypeptides for polymer conjugation |
| 01/25/2006 | EP1617867A1 Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates |
| 01/25/2006 | EP1617866A2 Modified live vaccines comprising bhv-1 (ibr) and/or bvdv for pregnant and nursing cattles |
| 01/25/2006 | EP1617865A2 Enhanced hiv-1 vaccines and methods for their use |
| 01/25/2006 | EP1617864A2 Epha2 and non-neoplastic hyperproliferative cell disorders |
| 01/25/2006 | EP1617863A2 Compositions and methods for wt1 specific immunotherapy |
| 01/25/2006 | EP1617854A2 Biologically active native biomatrix composition |
| 01/25/2006 | EP1617845A2 Compositions and methods for induction of opioid receptors |
| 01/25/2006 | EP1617805A2 Methods of preventing or treating respiratory conditions |
| 01/25/2006 | EP1617804A2 Improved heat shock protein-based vaccines and immunotherapies |
| 01/25/2006 | EP1151121B1 Recombined porcine adenovirus based viral vaccines and vectors |
| 01/25/2006 | EP1144650B1 Goodpasture antigen binding protein |
| 01/25/2006 | EP1062325B1 Purification of virus preparations |
| 01/25/2006 | EP0980427B1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 01/25/2006 | EP0759781B1 Compositions for treating and preventing atherosclerosis |
| 01/25/2006 | CN1726285A Methods and compositions for immunization against HIV |
| 01/25/2006 | CN1726276A Production of ALVAC on avian embryonic stem cells |
| 01/25/2006 | CN1726227A Humanized antibody (H14.18) of the mouse 14.18 antibody binding to GD2 and its fusion with 1L-2 |
| 01/25/2006 | CN1726226A Antibodies that bind cell-associated CA125/0722P and methods of use thereof |
| 01/25/2006 | CN1726047A Vaccine comprising an antigen conjugated to low valency anti-CD40 or anti-CD28 antibodies |
| 01/25/2006 | CN1724666A Immune tbid gene and its coded protein and application |
| 01/25/2006 | CN1724570A Anthrax toxin acceptor ATR-Fc fusion protein |
| 01/25/2006 | CN1724560A Antigen simulating epipeptide of C type para chicken blood phili bacillus and its use |
| 01/25/2006 | CN1724559A Antigen simulating epipeptide of A type parachicken blood phili bacillus and its use |
| 01/25/2006 | CN1724073A Suspension-aid agent for vaccine of coccidiosis |
| 01/25/2006 | CN1724070A Method for preparing agglutinative antigen of cholera fowl |
| 01/25/2006 | CN1724069A Method for preparing vaccine of fowl infectious coryza |
| 01/25/2006 | CN1724068A Method for preparing intensified inactivated cholera fowl vaccine |
| 01/25/2006 | CN1238506C CpG DNA gene engineering recombinant for livestock and bird vaccine adjuvant |
| 01/24/2006 | US6989452 Anticancer agents |
| 01/24/2006 | US6989436 Stabilization of cardiac troponin I subunits and complexes |
| 01/24/2006 | US6989365 Methods of treatment with erythropoietin and albumin fusion protein |
| 01/24/2006 | US6989255 for protection against staphylococcus infection; fusion proteins |
| 01/24/2006 | US6989148 Treatment of diabetes |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | US6989145 Chimeric antibody for use in the diagnosis and treatment of blood cancer and immune defects |
| 01/24/2006 | US6989144 Glycoprotein VI antibodies and uses thereof |
| 01/24/2006 | CA2351315C Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 01/23/2006 | CA2513024A1 Vibrio cholerae lps detoxified derivatives and immunogenic compositions containing them |
| 01/23/2006 | CA2475736A1 Vibrio cholerae lps detoxified derivatives and immunogenic compositions containing them |
| 01/21/2006 | CA2512515A1 Super-antigen fusion proteins and the use thereof |
| 01/19/2006 | WO2006007558A2 Novel compositions and methods in cancer |
| 01/19/2006 | WO2006007515A2 Functional assessment, specific enrichment and specific depletion of alloreactive human t cells |
| 01/19/2006 | WO2006007486A2 COMPOSITIONS AND METHODS FOR MODULATION OF RORϜt |
| 01/19/2006 | WO2006007398A1 Therapy of platinum-resistant cancer |
| 01/19/2006 | WO2006007366A2 SKIN IMMUNIZATION USING LT-STa FUSION PROTEINS |
| 01/19/2006 | WO2006006693A1 Anti-glypican 3 antibody |
| 01/19/2006 | WO2006005943A1 Phage screening assay |
| 01/19/2006 | WO2006005825A2 Novel polypeptides for isolating in vitro and preventing staphyloccocal infections on joint prostheses and other implanted foreign materials |
| 01/19/2006 | WO2006005707A2 Method for preventing and treating alzheimer´s disease |
| 01/19/2006 | WO2006005535A1 Reagents for diagnosis and therapy of latex allergy and method for the preparation of the same |
| 01/19/2006 | WO2006005477A1 Combination therapywith radiolabeled anti-cd20 antibody in the treatment of b-cell lymphoma |
| 01/19/2006 | WO2005105140A3 Meningococcal conjugate vaccination |
| 01/19/2006 | WO2005079315A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 01/19/2006 | WO2005035723A3 Tyrosinase mutant and methods of use thereof |
| 01/19/2006 | WO2004100640A3 Marek’s disease virus vaccine |
| 01/19/2006 | WO2004094620A3 Truncated baff receptors |
| 01/19/2006 | WO2004028472A3 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β |
| 01/19/2006 | US20060015969 Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases |
| 01/19/2006 | US20060014937 Humanized antibody against S-surface antigen of hepatitis B virus |
| 01/19/2006 | US20060014930 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 01/19/2006 | US20060014926 Human papillomavirus E6 and E7 polypeptides, mutant polypeptide retains 30% of the immunogenicity of an isolated polypeptide comprising human wild-type papillomavirus E6 and E7 |
| 01/19/2006 | US20060014717 Therapeutic compositions for use in prophylaxis or treatment of diarrheas |
| 01/19/2006 | US20060014714 Genetic induction of anti-viral immune response and genetic vaccine for viruses |
| 01/19/2006 | US20060014695 Hpma-polyamine conjugates and uses therefore |
| 01/19/2006 | US20060014672 Tumor specific oligosaccharide epitopes and use thereof |
| 01/19/2006 | US20060014245 Immunotoxins containing a cytotoxic RNAse fused to the N-terminus of one antibody variable domain prepared and retain the ability to specifically bind antigen; cancer |
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014222 Antibodies |
| 01/19/2006 | US20060014204 Methods of inducing formation of functional and organized lymphatic vessels |
| 01/19/2006 | US20060014148 Igg fc/hiv-gp120/c3d fusion protien |
| 01/19/2006 | US20060014139 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 01/19/2006 | US20060013883 Poloxamer and poloxamine compositions for nucleic acid delivery |
| 01/19/2006 | US20060013860 Anticancer agents; side effect reduction |
| 01/19/2006 | US20060013855 Bioactive stents for type II diabetics and methods for use thereof |
| 01/19/2006 | US20060013832 Methods for treating HIV infected subjects |
| 01/19/2006 | US20060013831 adjuvant peptide and heterologous an antigen; human immunodeficiency virus (HIV)-related peptides; antigen is cholera toxin; fusion protein |
| 01/19/2006 | US20060013830 Administering whole cell of Rhodococcus coprophilus; post weaning multisystemic wasting syndrome (PMWS) and/or porcine dermatitis and nephropathy syndrome (PDNS) |
| 01/19/2006 | US20060013829 Nucleic acid segments; coding zones; genetic engineered cells |
| 01/19/2006 | US20060013828 Isolated avirulent form of a carp virus, a double stranded DNA virus having a capsid with a icosahedron morphology and being of 90-110 nm in size and having 250,000 - 300,000 base pairs; causative agent of the disease affecting Cyprinus carpino; fish vaccines |
| 01/19/2006 | US20060013827 Method of diagnosing FIV |
| 01/19/2006 | US20060013826 Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions |
| 01/19/2006 | US20060013824 RSV proteins, antibodies, compositions, methods and uses |
| 01/19/2006 | US20060013823 Administering LK6/68 proteins in which sequence is identical to apolipoprotein kringle domains to reduce tumor growth; recombinant Escherichia; for treatment of cancer, rheumatoid arthritis, and psoriasis |
| 01/19/2006 | US20060013822 Utilization of mhc class II binding motifs in immunization to produce immune, serum, monoclonal antibodies and vaccines |
| 01/19/2006 | US20060013821 Killed cells of Mycobacterium avium as immunogens and mineral oil; immunocontraceptive vaccines such as gonadotropin releasing hormone (GnRH) |
| 01/19/2006 | US20060013820 Antigen delivery vectors and constructs |
| 01/19/2006 | US20060013819 Therapy of platinum-resistant cancer |